Taysha Gene Therapies ROA 2020-2024 | TSHA

Current and historical return on assets (ROA) values for Taysha Gene Therapies (TSHA) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Taysha Gene Therapies ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-06-30 $-0.11B $0.20B -63.16%
2024-03-31 $-0.12B $0.15B -78.15%
2023-12-31 $-0.11B $0.17B -81.01%
2023-09-30 $-0.22B $0.20B -169.96%
2023-06-30 $-0.13B $0.08B -118.76%
2023-03-31 $-0.13B $0.10B -111.43%
2022-12-31 $-0.17B $0.13B -121.83%
2022-09-30 $-0.16B $0.11B -101.74%
2022-06-30 $-0.19B $0.14B -96.99%
2022-03-31 $-0.19B $0.17B -88.99%
2021-12-31 $-0.17B $0.21B -74.04%
2021-09-30 $-0.14B $0.24B -57.66%
2021-06-30 $-0.11B $0.24B -41.45%
2021-03-31 $-0.09B $0.24B -44.05%
2020-12-31 $-0.06B $0.26B -43.87%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.314B $0.015B
Taysha Gene Therapies Inc. is a patient-centric gene therapy company. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system. The company's product pipeline includes TSHA-101, TSHA-118, TSHA-102, TSHA-103 and TSHA-104 which are in clinical stage. Taysha Gene Therapies Inc. is based in Dallas, Texas.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Bausch Health Cos (BHC) Canada $3.597B 2.61
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00